Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Detalles Bibliográficos
Autores principales: Reisner, Colin, Fabbri, Leonardo M., Kerwin, Edward M., Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F., Ferguson, Gary T., Martinez, Fernando J., Donohue, James F., Darken, Patrick, St. Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563904/
https://www.ncbi.nlm.nih.gov/pubmed/28826397
http://dx.doi.org/10.1186/s12931-017-0638-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563904/
https://www.ncbi.nlm.nih.gov/pubmed/28826397
http://dx.doi.org/10.1186/s12931-017-0638-2

Ejemplares similares